- Home
- CYTK vs LFUS Comparison
CYTK vs LFUS Comparison
Compare CYTK & LFUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- LFUS
- Stock Information
- Founded
- CYTK 1997
- LFUS 1927
- Country
- CYTK United States
- LFUS United States
- Employees
- CYTK N/A
- LFUS N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- LFUS Electrical Products
- Sector
- CYTK Health Care
- LFUS Energy
- Exchange
- CYTK Nasdaq
- LFUS Nasdaq
- Market Cap
- CYTK 5.7B
- LFUS 5.9B
- IPO Year
- CYTK 2004
- LFUS N/A
- Fundamental
- Price
- CYTK $45.82
- LFUS $236.91
- Analyst Decision
- CYTK Buy
- LFUS Buy
- Analyst Count
- CYTK 15
- LFUS 5
- Target Price
- CYTK $83.64
- LFUS $278.75
- AVG Volume (30 Days)
- CYTK 1.1M
- LFUS 121.5K
- Earning Date
- CYTK 02-25-2025
- LFUS 01-28-2025
- Dividend Yield
- CYTK N/A
- LFUS 1.18%
- EPS Growth
- CYTK N/A
- LFUS N/A
- EPS
- CYTK N/A
- LFUS 7.78
- Revenue
- CYTK $3,219,000.00
- LFUS $2,195,070,000.00
- Revenue This Year
- CYTK N/A
- LFUS N/A
- Revenue Next Year
- CYTK $710.83
- LFUS $4.71
- P/E Ratio
- CYTK N/A
- LFUS $30.55
- Revenue Growth
- CYTK N/A
- LFUS N/A
- 52 Week Low
- CYTK $44.49
- LFUS $222.91
- 52 Week High
- CYTK $84.92
- LFUS $275.58
- Technical
- Relative Strength Index (RSI)
- CYTK 39.27
- LFUS 48.39
- Support Level
- CYTK $44.49
- LFUS $230.04
- Resistance Level
- CYTK $48.45
- LFUS $236.17
- Average True Range (ATR)
- CYTK 1.65
- LFUS 5.24
- MACD
- CYTK -0.08
- LFUS 0.20
- Stochastic Oscillator
- CYTK 23.50
- LFUS 56.16
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About LFUS Littelfuse Inc.
Littelfuse is a primary provider of circuit protection products (such as fuses and relays) into the transportation, industrial, telecommunications, and consumer electronics end markets. The firm is also increasing its power semiconductor business, where it predominantly serves industrial end markets and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.